OBIO
Price
$2.94
Change
+$0.05 (+1.73%)
Updated
Jul 7, 11:38 AM (EDT)
Capitalization
110.72M
PULM
Price
$6.78
Change
+$0.25 (+3.83%)
Updated
Jul 7, 12:03 PM (EDT)
Capitalization
23.85M
30 days until earnings call
Interact to see
Advertisement

OBIO vs PULM

Header iconOBIO vs PULM Comparison
Open Charts OBIO vs PULMBanner chart's image
Orchestra BioMed Holdings
Price$2.94
Change+$0.05 (+1.73%)
Volume$200
Capitalization110.72M
Pulmatrix
Price$6.78
Change+$0.25 (+3.83%)
Volume$571
Capitalization23.85M
OBIO vs PULM Comparison Chart in %
Loading...
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OBIO vs. PULM commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OBIO is a Hold and PULM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (OBIO: $2.89 vs. PULM: $6.53)
Brand notoriety: OBIO and PULM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OBIO: 28% vs. PULM: 41%
Market capitalization -- OBIO: $110.72M vs. PULM: $23.85M
OBIO [@Biotechnology] is valued at $110.72M. PULM’s [@Biotechnology] market capitalization is $23.85M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OBIO’s FA Score shows that 0 FA rating(s) are green whilePULM’s FA Score has 0 green FA rating(s).

  • OBIO’s FA Score: 0 green, 5 red.
  • PULM’s FA Score: 0 green, 5 red.
According to our system of comparison, PULM is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OBIO’s TA Score shows that 5 TA indicator(s) are bullish while PULM’s TA Score has 3 bullish TA indicator(s).

  • OBIO’s TA Score: 5 bullish, 4 bearish.
  • PULM’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, OBIO is a better buy in the short-term than PULM.

Price Growth

OBIO (@Biotechnology) experienced а -3.02% price change this week, while PULM (@Biotechnology) price change was -6.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.52%. For the same industry, the average monthly price growth was +13.89%, and the average quarterly price growth was -0.53%.

Reported Earning Dates

PULM is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+5.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OBIO($111M) has a higher market cap than PULM($23.8M). PULM YTD gains are higher at: -6.447 vs. OBIO (-27.750). PULM has higher annual earnings (EBITDA): -9.58M vs. OBIO (-68.48M). OBIO has more cash in the bank: 49.9M vs. PULM (7.71M). PULM has less debt than OBIO: PULM (0) vs OBIO (16.4M). OBIO has higher revenues than PULM: OBIO (2.89M) vs PULM (1.92M).
OBIOPULMOBIO / PULM
Capitalization111M23.8M466%
EBITDA-68.48M-9.58M715%
Gain YTD-27.750-6.447430%
P/E RatioN/AN/A-
Revenue2.89M1.92M150%
Total Cash49.9M7.71M647%
Total Debt16.4M0-
FUNDAMENTALS RATINGS
PULM: Fundamental Ratings
PULM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OBIOPULM
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
57%
Bullish Trend 5 days ago
78%
Momentum
ODDS (%)
Bearish Trend 5 days ago
58%
Bearish Trend 5 days ago
84%
MACD
ODDS (%)
Bearish Trend 5 days ago
44%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
60%
Bearish Trend 5 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
61%
Bearish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
61%
Bullish Trend 11 days ago
70%
Declines
ODDS (%)
Bearish Trend 8 days ago
72%
Bearish Trend 18 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
63%
Bullish Trend 5 days ago
77%
Aroon
ODDS (%)
Bullish Trend 5 days ago
64%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PULM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEVM0.160.01
+4.00%
Phoenix Motor Inc
ABMRF26.80N/A
N/A
ABN Amro Group NV
GUKYF2.25N/A
N/A
Gulf Keystone Petroleum Ltd.
LGDDF22.68N/A
N/A
LAGARDERE SA
FMCCI17.67-0.27
-1.53%
Freddie Mac

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with XERS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then XERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
+0.35%
XERS - OBIO
40%
Loosely correlated
N/A
GLSI - OBIO
39%
Loosely correlated
+1.52%
ARWR - OBIO
39%
Loosely correlated
-0.65%
GBIO - OBIO
39%
Loosely correlated
+1.51%
RXRX - OBIO
39%
Loosely correlated
+1.15%
More

PULM and

Correlation & Price change

A.I.dvisor tells us that PULM and INM have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PULM and INM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PULM
1D Price
Change %
PULM100%
-6.71%
INM - PULM
29%
Poorly correlated
-4.59%
CRIS - PULM
24%
Poorly correlated
+3.43%
CERO - PULM
23%
Poorly correlated
-2.11%
MOLN - PULM
23%
Poorly correlated
N/A
OBIO - PULM
22%
Poorly correlated
+0.35%
More